Fundz
Free weekly newsletter

Get the free weekly funding digest

The new funding rounds, who’s behind them, and what they mean — delivered to your inbox every week. No credit card, unsubscribe anytime.

Weekly Digest

New funding rounds, summarized for you

Straight to Inbox

No login, no app to check — it comes to you

Industry Trends

See who's moving and how much in your market

No credit card required Weekly funding digest

RIS Rx received a growth investment from Summit Partners. The funding amount was not disclosed, aimed at supporting innovation and improving patient access to treatment.

PRIVATEJun 17, 2025•about 1 year ago
Newport BeachBiotechnologyHealth Care

Investors

Summit Partners

Description

RIS Rx, a Newport Beach, CA-based healthcare technology company, received a growth investment from Summit Partners. The amount of the deal was not disclosed. The company intends to use the funds to support its continued innovation and growth in services to improving patient access to treatment. Founded in 2020, RIS Rx is transforming pharmaceutical management.

Company Information

Company

RIS Rx

Location

Newport Beach, California, United States

About

RIS Rx is a healthcare technology company transforming pharmaceutical manufacturers' management of gross-to-net leakage. Through proprietary software and pharmacist-led expertise, RIS Rx empowers clients to optimize operations, eliminate leakage and ensure that financial assistance reaches the patients who need it most. Founded in 2020 and headquartered in Newport Beach, California, RIS Rx serves leading pharma manufacturers across a growing portfolio of drug brands.

Related People

Suggested for you
1 contact

Choose your plan to reveal verified contacts

Predictive Intelligence
Strategic

ML-powered predictions for RIS Rx's next move

Learn about Strategic plan

Funding Insights

Based on industry data
VC-backed spending patterns
VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.

Watching RIS Rx? See every signal — funding, hires, M&A, contracts, sentiment.

Request a demoChoose your plan